We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
826
Consolidated Edison
ED
$39.9B
$44.7M 0.01%
555,274
+15,200
+3% +$1.14M
ITUB icon
827
Itaú Unibanco
ITUB
$81.6B
$44.4M 0.01%
10,662,751
-2,006,411
-16% -$7.73M
PFSI icon
828
PennyMac Financial
PFSI
$4B
$44.3M 0.01%
3,547,500
+25,740
+0.7% +$334K
NVDA icon
829
NVIDIA
NVDA
$5.43T
$44.2M 0.01%
37,615,440
-169,600
-0.4% -$175K
NCI
830
DELISTED
Navigant Consulting, Inc.
NCI
$44.2M 0.01%
2,736,362
+16,300
+0.6% +$257K
PEG icon
831
Public Service Enterprise Group
PEG
$37.8B
$44.1M 0.01%
945,702
+28,775
+3% +$1.31M
VTR icon
832
Ventas
VTR
$45.7B
$44.1M 0.01%
605,253
+3,100
+0.5% +$204K
DFS
833
DELISTED
Discover Financial Services
DFS
$44.1M 0.01%
822,024
+1,695
+0.2% +$92.2K
AIT icon
834
Applied Industrial Technologies
AIT
$13B
$43.9M 0.01%
973,162
+1,200
+0.1% +$53.8K
AEGN
835
DELISTED
Aegion Corp
AEGN
$43.9M 0.01%
2,251,590
-42,600
-2% -$852K
LLTC
836
DELISTED
Linear Technology Corp
LLTC
$43.7M 0.01%
938,693
-6,810
-0.7% -$311K
AGU
837
DELISTED
Agrium
AGU
$43.7M 0.01%
482,940
-105,600
-18% -$9.4M
SU icon
838
Suncor Energy
SU
$74.7B
$43.1M 0.01%
1,555,725
-7,295,292
-82% -$200M
PKG icon
839
Packaging Corp of America
PKG
$22.8B
$43.1M 0.01%
643,827
-928,983
-59% -$60.7M
LTRPA
840
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$43M 0.01%
1,963,648
-12,500
-0.6% -$275K
TESO
841
DELISTED
Tesco Corp
TESO
$42.9M 0.01%
6,405,670
+368,810
+6% +$2.86M
ZBH icon
842
Zimmer Biomet
ZBH
$18.7B
$42.8M 0.01%
366,371
+28,164
+8% +$3.19M
PFGC icon
843
Performance Food Group
PFGC
$16.9B
$42.8M 0.01%
1,589,237
-11,033
-0.7% -$279K
WWW icon
844
Wolverine World Wide
WWW
$1.48B
$42.7M 0.01%
2,101,570
-7,640
-0.4% -$142K
STI
845
DELISTED
SunTrust Banks, Inc.
STI
$42.7M 0.01%
1,038,637
-89,121
-8% -$3.64M
RES icon
846
RPC Inc
RES
$1.4B
$42.6M 0.01%
2,745,508
-4,027,500
-59% -$59M
AMT.PRA
847
DELISTED
American Tower Corporation
AMT.PRA
$42.6M 0.01%
382,515
-3,025
-0.8% -$325K
SPNT icon
848
SiriusPoint
SPNT
$2.66B
$42.6M 0.01%
3,635,570
-266,000
-7% -$3.02M
NLSN
849
DELISTED
Nielsen Holdings plc
NLSN
$42.3M 0.01%
814,246
+12,796
+2% +$675K
GLW icon
850
Corning
GLW
$144B
$42.2M 0.01%
2,059,187
-19,060
-0.9% -$382K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.